Shenghua L. Sun
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study.
Journal: Cancer communications (London, England)
Published: November 29, 2025
Smad7 ameliorate small airway remodeling in COPD by modulating epithelial-mesenchymal transition.
Journal: Tobacco induced diseases
Published: February 19, 2025
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study.
Journal: The Lancet. Respiratory medicine
Published: August 11, 2024
Bilirubin nanoparticles modulate Treg/Th17 cells and functional metabolism of gut microbiota to inhibit lung adenocarcinoma.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: August 01, 2024
Benefits of CMAB007 in Chinese Patients Having Inadequately Controlled Moderate/Severe Asthma With Increased Total IgE: A Randomized Phase 3 Trial.
Journal: Allergy, asthma & immunology research
Published: June 27, 2024
Intravenous injection of BMSCs modulate tsRNA expression and ameliorate lung remodeling in COPD mice.
Journal: Stem cell research & therapy
Published: June 18, 2024
Efficacy and Safety of Biosimilar SCT510 Compared with Bevacizumab for the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study.
Journal: Advances in therapy
Published: May 28, 2024
A multicentre, randomised, double-blind, double-dummy, parallel-controlled, phase 3 clinical trial assessing the efficacy and safety of intravenous nemonoxacin malate vs. levofloxacin for community-acquired pneumonia in adult patients.
Journal: International journal of antimicrobial agents
Published: November 29, 2023
Effects of microRNA-21 on endothelial-to-mesenchymal transition and its role in the pathogenesis of chronic obstructive pulmonary disease.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: May 10, 2023
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 22, 2023
Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies.
Journal: Chinese medical journal
Published: February 08, 2023
Last Updated: 09/26/2026